The global bioinformatics market is projected to grow from $18.63 billion in 2026 to $34.41 billion by 2031, at a CAGR of 13.1% during the forecast period. Market growth is being driven by the rapid integration of artificial intelligence (AI), machine learning (ML), and cloud computing into bioinformatics workflows, enabling faster, more accurate, and scalable analysis of complex biological data.
Market Drivers
The increasing adoption of next-generation sequencing (NGS) technologies and the rising demand for precision medicine are significantly boosting the need for advanced bioinformatics solutions. Cloud-based platforms are further supporting market expansion by enabling secure data storage, scalable computing resources, and real-time collaboration across research institutions, healthcare providers, and pharmaceutical companies.
The Asia Pacific region is expected to register the highest growth rate during the forecast period. Growth in this region is driven by increasing adoption of NGS technologies, rising investments in genomics research, and expanding biotechnology and pharmaceutical sectors.
Original reporting: KTBS 3 (Shreveport) — read the source article.
